Newsletter | August 5, 2025

08.05.25 -- Outsourced, In-House, Or A Combo?

SPONSOR

The Festival of Biologics is the meeting place for the life science community to bridge the gap between academia and industry, covering the start to finish of biologics from discovery, through development, to manufacturing, clinical trials and commercialisation. Register now to join Europe's largest biologics event and use LSC20 to get 20% off!

FOCUS ON OUTSOURCING

Outsourced, In-House, Or A Combo: An Agile Recruiting Strategy Fuels Growth In Pharmas And Biotechs

By Ruba Asmussen, RTA Consulting

There are different staffing options for building an agile and scalable team that can quickly react to shifting needs, resources, and funding.

Tech Transfer: 7 Unique Challenges For Advanced Therapeutics

Article | Minaris Advanced Therapies

Ensure the success of your tech transfer by addressing these key challenges and optimizing your processes for seamless scalability and compliance.

Unravelling The Complexities Of ADC Development And Manufacturing

White Paper | Pfizer CentreOne

Whether you're in the early stages of development or scaling up for commercialization, understanding ADC manufacturing challenges is essential for bringing life-saving therapies to patients worldwide.

Overcoming Challenges In Combination Product Manufacturing

Article | Argonaut Manufacturing Services

Blending pharmaceuticals and medical devices into a single product offers immense potential for patient care, but manufacturing these combination products presents unique hurdles.

Current And Emerging Technologies To Optimize mRNA Manufacturing

Article | By Clemens Jakobi, Michał Domański, and Telmo Graça, Lonza

Explore the benefits of using mRNA for vaccines and therapeutics, and learn how to address technical, intellectual property, and cost considerations when considering commercial production.

ICP-MS And ICP-OES: Tools For Elemental Impurity Analysis

Article | By Julia Spraul and Alyssa McBurney, Alcami

Leverage advanced elemental impurity testing methods to ensure the safety, compliance, and accuracy of your drug products throughout the manufacturing process.

OUTSOURCING SOLUTIONS

•

Advancing CRISPR-Based Therapeutic Development - Aldevron

•

Bionanoparticle Technology - Nanoform

Connect With Bioprocess Online: